New Systemic Therapies for Metastatic Breast Cancer, Including SABCS Updates
This information was originally presented at the NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium (SABCS) held in Chicago, Illinois, on February 8, 2019.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Genetic/Familial High-Risk Evaluation in Patients with Breast Cancer
Individuals found to have a hereditary breast cancer syndrome should be managed appropriately, with an emphasis on screening considerably earlier than standard recommendations.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging
With the release of the 8th edition of the AJCC staging manual,  it is important for clinicians to be aware of the updates to the AJCC TNM staging in order to select appropriate treatment, evaluate treatment outcomes, participate in clinical trials, and facilitate accurate information sharing amo
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Locoregional Treatment of Breast Cancer, Including SABCS Updates
Locoregional management strategies have considerably evolved.  Although several randomized studies have identified patients that do not need ALND, a recent survey revealed substantial variation in surgeon management suggesting the potential for overtreatment of many patients and the need for educ
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Neoadjuvant and Adjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates
This information was originally presented at the NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium (SABCS) held in Chicago, Illinois, on February 8, 2019.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Breast Cancer - Multigene Testing in Breast Cancer
Numerous multigene-based assays have been developed to better prognosticate the risk of recurrence and death and predict benefit of therapy.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Breast Cancer - Treatment of HR-Positive, HER-Negative Advanced Breast Cancer
The endocrine therapy options are expanding for patients with early stage and advanced stage disease.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenges with the 8th Edition of the AJCC Staging Manual - Staging of Breast Cancer
As research on clinical cancer care rapidly evolves, utilizing and implementing a staging system that is primarily based on prognostic information may have limitations.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Harmonized Guidelines™ for Sub-Saharan Africa
Clinicians around the world use NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) as a standard for clinical decision-making.  The NCCN Harmonized Guidelines™ are targeted regional resources created as part of a collaborative effort to combat the skyrocketing cancer rate
Category
  • Breast Cancer
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing
The goal of this activity is to improve participants' knowledge of, confidence in, and competence in integrating PARP inhibitors into treatment of patients with breast cancer.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages